Transgene Biotek

quarterly
yearly
ParticularsJun '21Sep '21Dec '21Mar '22Jun '22
Revenue0.000.010.000.080.06
Expenses2.602.592.632.651.44
EBITDA-2.60-2.58-2.63-2.57-1.38
EBIT-5.07-5.05-5.10-5.08-2.62
Profit Before Tax-2.61-2.60-2.64-2.55-1.39
Net Profit-2.61-2.60-2.64-2.55-1.39
Financial Ratios
Operating Profit MarginNA%-25,900%NA%-3,212%-2,317%
Net Profit MarginNA%-26,000%NA%-3,187%-2,317%
Earning Per Share (Diluted)-0.34-0.34-0.35-0.33-0.18
Dividends Per ShareNANANANANA
ⓒ 2016-2022 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 3.3.8
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  ICICI PRUDENTIAL |  HDFC |  NIPPON INDIA |  ADITYA BIRLA SUN LIFE |  SBI |  UTI |  FRANKLIN TEMPLETON |  KOTAK MAHINDRA |  IDFC |  DSP |  AXIS |  TATA |  L&T |  SUNDARAM |  PGIM |  INVESCO |  LIC |  JM FINANCIAL |  BARODA PIONEER |  CANARA ROBECO |  HSBC |  IDBI |  INDIABULLS |  MOTILAL OSWAL |  BNP PARIBAS |  MIRAE ASSET |  PRINCIPAL |  BOI AXA |  UNION KBC |  TAURUS |  EDELWEISS |  NAVI |  MAHINDRA |  QUANTUM |  PPFAS |  IIFL |  Quant |  SHRIRAM |  SAHARA |  ITI